HR 796In Committee
Second Chance for Moms Act
Introduced January 28, 2025
Summary
Second Chance for Moms Act of 2025This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)
Timeline
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
See how this bill affects you
Enter your details to get a personalized impact estimate.
Check your impact